Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma.
Chen, Shuling
Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma. [electronic resource] - Cancer medicine 04 2019 - 1530-1539 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
2045-7634
10.1002/cam4.2038 doi
Carcinoma, Hepatocellular--mortality
Chemoembolization, Therapeutic--adverse effects
Hepatectomy--adverse effects
Humans
Liver Neoplasms--mortality
Markov Chains
Neoplasm Staging
Prognosis
Propensity Score
Survival Rate
Treatment Outcome
Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma. [electronic resource] - Cancer medicine 04 2019 - 1530-1539 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
2045-7634
10.1002/cam4.2038 doi
Carcinoma, Hepatocellular--mortality
Chemoembolization, Therapeutic--adverse effects
Hepatectomy--adverse effects
Humans
Liver Neoplasms--mortality
Markov Chains
Neoplasm Staging
Prognosis
Propensity Score
Survival Rate
Treatment Outcome